의약품용 유리 포장 시장 규모, 점유율, 성장, 세계 산업 분석, 지역별 인사이트 및 예측(2026-2034년)

Growth Factors of pharmaceutical glass packaging Market

The global pharmaceutical glass packaging market is witnessing significant growth, supported by the expansion of the pharmaceutical industry, increasing healthcare expenditure, rising demand for medicines, and advancements in pharmaceutical manufacturing. The global pharmaceutical glass packaging market size was valued at USD 24.29 billion in 2025 and is projected to grow to USD 26.94 billion in 2026. The market is expected to reach USD 61.63 billion by 2034, exhibiting a CAGR of 10.90% from 2026 to 2034. North America dominated the market with a 33.6% share in 2025.

Pharmaceutical glass packaging is used to protect medicines from physical damage, contamination, moisture, air, and other external influences. Glass offers chemical inertness, transparency, rigidity, recyclability, and sterilization capabilities, making it suitable for pharmaceutical bottles, vials, ampoules, cartridges, and syringes. Increasing demand for pharmaceutical drugs, biologics, generic medicines, and injectable products is expected to support the market through 2034.

Market Definition and Scope

The pharmaceutical glass packaging market covers glass containers and packaging solutions designed specifically for pharmaceutical products. Major products include vials and ampoules, bottles, cartridges, and syringes. The market encompasses packaging used for generic, branded, and biologic drugs across pharmaceutical manufacturing and healthcare applications.

Market Dynamics

Drivers

The global expansion of the pharmaceutical industry is a major growth driver. Increasing healthcare spending, rising disease prevalence, population growth, and greater health awareness are increasing demand for medicines and, consequently, pharmaceutical packaging. Glass is preferred because it provides strong protection and is resistant to moisture and air.

Technological advancements in pharmaceutical manufacturing are also creating opportunities. The development of advanced glass formulations, improved manufacturing processes, and packaging technologies is helping manufacturers enhance product safety and minimize contamination risks.

Trends

The adoption of new glass types to minimize pharmaceutical contamination is an important market trend. Boron-free pharmaceutical glass can provide more uniform chemistry and improved chemical durability. Manufacturers are also adopting technologies such as permanent engraving and advanced packaging designs to improve product identification and address counterfeiting concerns.

Restraints

The increasing adoption of alternative packaging materials, particularly plastics, may restrain market growth. Plastic packaging offers lightweight construction, flexibility, impact resistance, easy molding, and lower transportation costs. Plastic bottles and cartridges can also reduce the risk of accidental breakage compared with glass containers.

Impact of COVID-19

The COVID-19 pandemic increased the importance of pharmaceutical packaging because of the need for vaccines, medicines, and other healthcare products. Demand for vials, syringes, and other pharmaceutical glass containers increased as pharmaceutical companies expanded vaccine and treatment production. At the same time, supply-chain disruptions and manufacturing restrictions created challenges for packaging manufacturers. The pandemic also accelerated investments in pharmaceutical manufacturing and packaging capacity.

Segmentation Analysis

By product, the market is segmented into vials & ampoules, bottles, cartridges, and syringes. The bottles segment held the largest market share in 2025, supported by their chemical inertness, rigidity, and protective properties. Bottles are widely used for tablets, capsules, syrups, and ophthalmic products.

Vials and ampoules are expected to witness strong demand because they protect pharmaceutical products from atmospheric gases and contamination. Syringes and cartridges are also gaining importance due to increasing demand for injectable and self-administered pharmaceutical products.

By drug type, the market is divided into generic, branded, and biologic drugs. The generic segment is the fastest-growing drug type, supported by lower costs, government initiatives encouraging generic medicines, patent expirations, and increasing demand in developing economies. Biologic drugs are also supporting packaging demand because of their increasing use in chronic and autoimmune disease treatment.

Regional Insights

North America dominated the market with a 33.6% share in 2025, supported by pharmaceutical industry expansion, high healthcare spending, and strong demand for pharmaceutical products. The U.S. is the major contributor to regional growth.

Europe is the second-largest market, with Germany, the U.K., and Italy contributing significantly. Government guidelines, pharmaceutical manufacturing, and healthcare investments are supporting demand.

Asia Pacific is witnessing strong growth due to increasing pharmaceutical manufacturing investments in China, Japan, and India. Expansion of pharmaceutical companies and rising healthcare demand are creating opportunities for glass packaging manufacturers.

Latin America is supported by a growing geriatric population, healthcare awareness, and favorable government policies, while the Middle East & Africa is benefiting from expanding pharmaceutical manufacturing capabilities and healthcare investments.

Competitive Landscape

The competitive landscape is fragmented, with leading companies focusing on product innovation, research and development, manufacturing expansion, acquisitions, and advanced pharmaceutical packaging technologies. Key companies include Corning Inc., Nipro Corporation, SCHOTT, Gerresheimer AG, SGD S.A., Stolzle-Oberglas, Bormioli Pharma, West Pharmaceutical Services, Shandong Medicinal Glass, Beatson Clark, and Sisecam Group.

Recent developments include Nipro Pharma's agreement with AstraZeneca for vaccine fill-and-finish manufacturing, Stoelzle Glass Group's acquisition of Anchor Hocking's Monaca facility, and SCHOTT's investment in a pharmaceutical tubing factory in China.

Report Coverage

The pharmaceutical glass packaging market report covers market size and forecast for 2025, 2026, and 2034, product and drug-type segmentation, regional analysis, market drivers, trends, restraints, COVID-19 impact, competitive landscape, company profiles, and key industry developments. The report also examines packaging technologies, materials, sterilization methods, and pharmaceutical applications.

Conclusion

The global pharmaceutical glass packaging market is projected to grow from USD 24.29 billion in 2025 to USD 26.94 billion in 2026 and reach USD 61.63 billion by 2034, at a CAGR of 10.90%. Growing pharmaceutical production, rising healthcare expenditure, increasing demand for generic and biologic medicines, and technological advancements in pharmaceutical glass are expected to drive market expansion. North America remains a leading market, while Asia Pacific presents substantial growth opportunities through expanding pharmaceutical manufacturing. Meanwhile, competition from lightweight and cost-effective plastic packaging remains a key challenge. Innovation in pharmaceutical glass technology, contamination prevention, and advanced packaging solutions is expected to shape the market through 2034.

ATTRIBUTES DETAILS

Segmentation

By Product

• Vials & Ampoules
• Bottles
• Cartridges
• Syringes

By Drug Type

• Generic
• Branded
• Biologic

By Geography

• North America
  • By Product
  • By Drug Type
  • By Country
• U.S. (By Drug Type)
• Canada (By Drug Type)
• Europe
  • By Product
  • By Drug Type
  • By Country
• Germany (By Drug Type)
• UK (By Drug Type)
• France (By Drug Type)
• Italy (By Drug Type)
• Spain (By Drug Type)
• Rest of Europe (By Drug Type)
• Asia Pacific
  • By Product
  • By Drug Type
  • By Country
• China (By Drug Type)
• Japan (By Drug Type)
• India (By Drug Type)
• Rest of Asia Pacific (By Drug Type)
• Latin America
  • By Product
  • By Drug Type
  • By Country
• Brazil (By Drug Type)
• Mexico (By Drug Type)
• Rest of Latin America (By Drug Type)
• Middle East & Africa
  • By Product
  • By Drug Type
  • By Country
• GCC (By Drug Type)
• Rest of Middle East & Africa (By Drug Type)

Table of Content

1. Introduction

• 1.1. Research Scope
• 1.2. Market SegHouseholdtation
• 1.3. Research Methodology
• 1.4. Definitions and Assumptions

2. Executive Summary

3. Market Dynamics

• 3.1. Market Drivers
• 3.2. Market Restraints
• 3.3. Market Opportunities

4. Key Insights

• 4.1. Key Market Trends in the Global Market
• 4.2. Key Developments: Mergers, Acquisition, Partnership, etc. .
• 4.3. Latest Technological Advancement
• 4.4. Insights on Regulatory Scenario
• 4.5. Porters Five Forces Analysis

5. Qualitative Insights Impact of COVID 19 on Global Pharmaceutical Glass Packaging Market

• 5.1. Supply Chain Challenges
• 5.2. Steps taken by Government/Companies to overcome this impact
• 5.3. Potential opportunities due to COVID-19 outbreak

6. Global Pharmaceutical Glass Packaging Market Analysis, Insights and Forecast, 2021-2034

• 6.1. Key Findings / Summary
• 6.2. Market Size Estimates and Forecast
  • 6.2.1. By Product (Value)
    • 6.2.1.1. Vials & Ampoules
    • 6.2.1.2. Bottles
    • 6.2.1.3. Cartridges
    • 6.2.1.4. Syringes
  • 6.2.2. By Drug Type (Value)
    • 6.2.2.1. Generic
    • 6.2.2.2. Branded
    • 6.2.2.3. Biologic
  • 6.2.3. By Region (Value)
    • 6.2.3.1. North America
    • 6.2.3.2. Europe
    • 6.2.3.3. Asia Pacific
    • 6.2.3.4. Latin America
    • 6.2.3.5. Middle East & Africa

7. North America Pharmaceutical Glass Packaging Market Analysis, Insights and Forecast, 2021-2034

• 7.1. Key Findings / Summary
• 7.2. Market Size Estimates and Forecast
  • 7.2.1. By Product (Value)
    • 7.2.1.1. Vials & Ampoules
    • 7.2.1.2. Bottles
    • 7.2.1.3. Cartridges
    • 7.2.1.4. Syringes
  • 7.2.2. By Drug Type (Value)
    • 7.2.2.1. Generic
    • 7.2.2.2. Branded
    • 7.2.2.3. Biologic
  • 7.2.3. By Country (Value)
    • 7.2.3.1. U.S
    • 7.2.3.2. Canada

8. Europe Pharmaceutical Glass Packaging Market Analysis, Insights and Forecast, 2021-2034

• 8.1. Key Findings / Summary
• 8.2. Market Size Estimates and Forecast
  • 8.2.1. By Product (Value)
    • 8.2.1.1. Vials & Ampoules
    • 8.2.1.2. Bottles
    • 8.2.1.3. Cartridges
    • 8.2.1.4. Syringes
  • 8.2.2. By Drug Type (Value)
    • 8.2.2.1. Generic
    • 8.2.2.2. Branded
    • 8.2.2.3. Biologic
  • 8.2.3. By Country (Value)
    • 8.2.3.1. Germany
    • 8.2.3.2. France
    • 8.2.3.3. U.K.
    • 8.2.3.4. Italy
    • 8.2.3.5. Spain
    • 8.2.3.6. Rest of Europe

9. Asia-Pacific Pharmaceutical Glass Packaging Market Analysis, Insights and Forecast, 2021-2034

• 9.1. Key Findings / Summary
• 9.2. Market Size Estimates and Forecast
  • 9.2.1. By Product (Value)
    • 9.2.1.1. Vials & Ampoules
    • 9.2.1.2. Bottles
    • 9.2.1.3. Cartridges
    • 9.2.1.4. Syringes
  • 9.2.2. By Drug Type (Value)
    • 9.2.2.1. Generic
    • 9.2.2.2. Branded
    • 9.2.2.3. Biologic
  • 9.2.3. By Country (Value)
    • 9.2.3.1. China
    • 9.2.3.2. Japan
    • 9.2.3.3. India
    • 9.2.3.4. Rest of Asia-Pacific

10. Latin America Pharmaceutical Glass Packaging Market Analysis, Insights and Forecast, 2021-2034

• 10.1. Key Findings / Summary
• 10.2. Market Size Estimates and Forecast
  • 10.2.1. By Product (Value)
    • 10.2.1.1. Vials & Ampoules
    • 10.2.1.2. Bottles
    • 10.2.1.3. Cartridges
    • 10.2.1.4. Syringes
  • 10.2.2. By Drug Type (Value)
    • 10.2.2.1. Generic
    • 10.2.2.2. Branded
    • 10.2.2.3. Biologic
  • 10.2.3. By Country (Value)
    • 10.2.3.1. Brazil
    • 10.2.3.2. Mexico
    • 10.2.3.3. Rest of Latin America

11. Middle East & Africa Pharmaceutical Glass Packaging Market Analysis, Insights and Forecast, 2021-2034

• 11.1. Key Findings / Summary
• 11.2. Market Size Estimates and Forecast
  • 11.2.1. By Product (Value)
    • 11.2.1.1. Vials & Ampoules
    • 11.2.1.2. Bottles
    • 11.2.1.3. Cartridges
    • 11.2.1.4. Syringes
  • 11.2.2. By Drug Type (Value)
    • 11.2.2.1. Generic
    • 11.2.2.2. Branded
    • 11.2.2.3. Biologic
  • 11.2.3. By Country (Value)
    • 11.2.3.1. GCC
    • 11.2.3.2. Rest of Middle East & Africa

12. Company Profiles

• 12.1. Corning Inc.
  • 12.1.1. Overview
  • 12.1.2. Description
  • 12.1.3. Product Portfolio
  • 12.1.4. Financials (Data as available in public domain and/or on paid databases)
  • 12.1.5. Recent DevelopHouseholdts
• 12.2. Nipro Corporation
  • 12.2.1. Overview
  • 12.2.2. Description
  • 12.2.3. Product Portfolio
  • 12.2.4. Financials (Data as available in public domain and/or on paid databases)
  • 12.2.5. Recent DevelopHouseholdts
• 12.3. SCHOTT
  • 12.3.1. Overview
  • 12.3.2. Description
  • 12.3.3. Product Portfolio
  • 12.3.4. Financials (Data as available in public domain and/or on paid databases)
  • 12.3.5. Recent DevelopHouseholdts
• 12.4. Gerresheimer AG
  • 12.4.1. Overview
  • 12.4.2. Description
  • 12.4.3. Product Portfolio
  • 12.4.4. Financials (Data as available in public domain and/or on paid databases)
  • 12.4.5. Recent DevelopHouseholdts
• 12.5. SGD S.A.
  • 12.5.1. Overview
  • 12.5.2. Description
  • 12.5.3. Product Portfolio
  • 12.5.4. Financials (Data as available in public domain and/or on paid databases)
  • 12.5.5. Recent DevelopHouseholdts
• 12.6. Stolzle-Oberglas GmbH
  • 12.6.1. Overview
  • 12.6.2. Description
  • 12.6.3. Product Portfolio
  • 12.6.4. Financials (Data as available in public domain and/or on paid databases)
  • 12.6.5. Recent DevelopHouseholdts
• 12.7. Bormioli Pharma
  • 12.7.1. Overview
  • 12.7.2. Description
  • 12.7.3. Product Portfolio
  • 12.7.4. Financials (Data as available in public domain and/or on paid databases)
  • 12.7.5. Recent DevelopHouseholdts
• 12.8. West Pharmaceutical Services, Inc
  • 12.8.1. Overview
  • 12.8.2. Description
  • 12.8.3. Product Portfolio
  • 12.8.4. Financials (Data as available in public domain and/or on paid databases)
  • 12.8.5. Recent DevelopHouseholdts
• 12.9. Shandong Medicinal Glass Co., Ltd.
  • 12.9.1. Overview
  • 12.9.2. Description
  • 12.9.3. Product Portfolio
  • 12.9.4. Financials (Data as available in public domain and/or on paid databases)
  • 12.9.5. Recent DevelopHouseholdts
• 12.10. Beatson Clark
  • 12.10.1. Overview
  • 12.10.2. Description
  • 12.10.3. Product Portfolio
  • 12.10.4. Financials (Data as available in public domain and/or on paid databases)
  • 12.10.5. Recent DevelopHouseholdts
• 12.11. Sisecam Group
  • 12.11.1. Overview
  • 12.11.2. Description
  • 12.11.3. Product Portfolio
  • 12.11.4. Financials (Data as available in public domain and/or on paid databases)
  • 12.11.5. Recent DevelopHouseholdts
• 12.12. Other Key Players
  • 12.12.1. Overview
  • 12.12.2. Description
  • 12.12.3. Product Portfolio
  • 12.12.4. Financials (Data as available in public domain and/or on paid databases)
  • 12.12.5. Recent DevelopHouseholdts

13. Strategic Recommendation